Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma PLC (GB:TCF)
LSE:TCF
Total Valuation
Evgen Pharma has a market cap or net worth of £4.08M. The enterprise value is -1.77M.
Market Cap£4.08M
Enterprise Value-1.77M
Share Statistics
Evgen Pharma has 2,148,963,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,148,963,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Evgen Pharma’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -38.05%.
Return on Equity (ROE)-0.33
Return on Assets (ROA)-0.25
Return on Invested Capital (ROIC)-38.05%
Return on Capital Employed (ROCE)-0.36
Revenue Per Employee0.00
Profits Per Employee-231.67K
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Evgen Pharma is ―. Evgen Pharma’s PEG ratio is 0.00912.
PE Ratio―
PS Ratio0.00
PB Ratio0.20
Price to Fair Value0.20
Price to FCF-0.51
Price to Operating Cash Flow-0.57
PEG Ratio0.00912
Income Statement
In the last 12 months, Evgen Pharma had revenue of 0.00 and earned -1.94M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-2.11M
Operating Income-2.12M
Pretax Income-2.08M
Net Income-1.94M
EBITDA-2.06M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -2.37M and capital expenditures 0.00, giving a free cash flow of -2.37M billion.
Operating Cash Flow-2.37M
Free Cash Flow-2.37M
Free Cash Flow per Share>-0.01
Dividends & Yields
Evgen Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change-59.62%
50-Day Moving Average0.21
200-Day Moving Average0.23
Relative Strength Index (RSI)62.53
Average Volume (3m)1.69M
Important Dates
Evgen Pharma upcoming earnings date is Jun 10, 2026, TBA (Confirmed).
Last Earnings DateDec 3, 2025
Next Earnings DateJun 10, 2026
Ex-Dividend Date―
Financial Position
Evgen Pharma as a current ratio of 3.11, with Debt / Equity ratio of 0.00%
Current Ratio3.11
Quick Ratio3.11
Debt to Market Cap0.00
Net Debt to EBITDA1.03
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Evgen Pharma has paid 144.00K in taxes.
Income Tax144.00K
Effective Tax Rate-0.07
Enterprise Valuation
Evgen Pharma EV to EBITDA ratio is 0.44, with an EV/FCF ratio of 0.38.
EV to Sales0.00
EV to EBITDA0.44
EV to Free Cash Flow0.38
EV to Operating Cash Flow0.38
Balance Sheet
Evgen Pharma has £4.11M in cash and marketable securities with £0.00 in debt, giving a net cash position of £4.11M billion.
Cash & Marketable Securities£4.11M
Total Debt£0.00
Net Cash£4.11M
Net Cash Per Share<£0.01
Tangible Book Value Per Share<£0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Evgen Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast85.56%